Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051

Next Previous
Trial Profile

An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 24 Jan 2019

At a glance

  • Drugs SRP-5051 (Primary)
  • Indications Duchenne muscular dystrophy
  • Focus Adverse reactions
  • Sponsors Sarepta Therapeutics

    • Most Recent Events

    • 16 Jan 2019 Status changed from not yet recruiting to recruiting.
    • 23 Nov 2018 Planned End Date changed from 30 Aug 2020 to 1 Nov 2020.
    • 23 Nov 2018 Planned primary completion date changed from 30 Apr 2020 to 1 Nov 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top